ASKA Pharmaceutical Holdings Co Ltd
TSE:4886

Watchlist Manager
ASKA Pharmaceutical Holdings Co Ltd Logo
ASKA Pharmaceutical Holdings Co Ltd
TSE:4886
Watchlist
Price: 2 050 JPY 0.69% Market Closed
Market Cap: 58.1B JPY
Have any thoughts about
ASKA Pharmaceutical Holdings Co Ltd?
Write Note
ASKA Pharmaceutical Holdings Co Ltd
/
Cash Flow Statement
/
Net Change in Cash

ASKA Pharmaceutical Holdings Co Ltd
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ASKA Pharmaceutical Holdings Co Ltd
Net Change in Cash Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
ASKA Pharmaceutical Holdings Co Ltd
TSE:4886
Net Change in Cash
-¥766m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Takeda Pharmaceutical Co Ltd
TSE:4502
Net Change in Cash
¥541B
CAGR 3-Years
N/A
CAGR 5-Years
19%
CAGR 10-Years
N/A
Daiichi Sankyo Co Ltd
TSE:4568
Net Change in Cash
¥116.9B
CAGR 3-Years
6%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Otsuka Holdings Co Ltd
TSE:4578
Net Change in Cash
-¥3.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Chugai Pharmaceutical Co Ltd
TSE:4519
Net Change in Cash
¥236.5B
CAGR 3-Years
189%
CAGR 5-Years
50%
CAGR 10-Years
N/A
Astellas Pharma Inc
TSE:4503
Net Change in Cash
-¥41B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

ASKA Pharmaceutical Holdings Co Ltd
Glance View

Market Cap
58.1B JPY
Industry
Pharmaceuticals

ASKA Pharmaceutical Holdings Co., Ltd. engages in the management of its group companies which are involved in the manufacture and sale of pharmaceuticals, quasi-drugs, food, veterinary drugs, feeds, feed additives, and medical devices. The company is headquartered in Minato-Ku, Tokyo-To. The company went IPO on 2021-04-01. The firm mainly operates in two business segments. The Pharmaceutical segment is mainly engaged in the manufacture, purchase and sale of pharmaceutical products. The Others segment is involved in the manufacture of veterinary drugs, the provision of clinical testing services, the outsourcing of testing services, the purchase and sale of medical equipment, as well as the sale of health foods.

Intrinsic Value
3 410.94 JPY
Undervaluation 40%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is ASKA Pharmaceutical Holdings Co Ltd's Net Change in Cash?
Net Change in Cash
-766m JPY

Based on the financial report for Mar 31, 2024, ASKA Pharmaceutical Holdings Co Ltd's Net Change in Cash amounts to -766m JPY.

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.